Scolaris Content Display Scolaris Content Display

Assisted reproductive technologies for male subfertility

Contraer todo Desplegar todo

Referencias

Arici 1994 {published data only}

Arici A, Byrd W, Bradshaw K, Kutteh WH, Marshburn P, Carr BR. Evaluation of clomiphene citrate and human chorionic gonadotropin treatment: a prospective, randomized, crossover study during intrauterine insemination cycles. Fertility & Sterility 1994;61:314‐8.

Bensdorp 2015 {published data only}

Bensdorp AJ, Tjon‐Kon‐Fat RI, Bossuyt PM, Koks CA, Oosterhuis GJ, Hoek A, et al. Prevention of multiple pregnancies in couples with unexplained or mild male subfertility: randomised controlled trial of in vitro fertilisation with single embryo transfer or in vitro fertilisation in modified natural cycle compared with intrauterine insemination with controlled ovarian hyperstimulation. BMJ 2015;350:7771.

Cohlen 1998a {published data only}

Cohlen BJ, te Velde ER, van Kooij RJ, Looman CWN, Habbema JDF. Controlled ovarian hyperstimulation and intrauterine insemination for treating male subfertility: a controlled study. Human Reproduction 1998;13:1553‐8.

Francavilla 2009 {published data only}

Francavilla F, Sciarretta F, Sorgentone S, Necozione S, Santucci R, Barbonetti A, et al. Intrauterine insemination with or without mild ovarian stimulation in couples with male subfertility due to oligo/astheno‐ and/or teratozoospermia or antisperm antibodies: a prospective cross‐over trial. Fertility & Sterility 2009;92:1009‐11.

Goverde 2000 {published data only}

Goverde AJ, Lambalk CB, McDonnel J, Schats R, Homburg R, Vermeiden JPW. Further considerations on natural or mild hyperstimulation cycles for intrauterine insemination treatment: effects on pregnancy and multiple pregnancy rates. Human Reproduction 2005;20(11):3141‐6.
Goverde AJ, McDonnell J, Vermeiden JPW, Schats R, Rutten FFH, Schoemaker J. Intrauterine insemination or in‐vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost‐effectiveness analysis. Lancet 2000;355:13‐8.

Gregoriou 1996 {published data only}

Gregoriou O, Vitoratos N, Papadias C, Konidaris S, Gargaropoulos A, Rizos D. Pregnancy rates in gonadotrophin stimulated cycles with timed intercourse or intrauterine insemination for the treatment of male subfertility. European Journal of Obstetrics & Gynaecology and Reproductive Biology 1996;64:213‐6.

Guzick 1999 {published data only}

Guzick DS, Carson SA, Coutifaris C, Overstreet JW, Factor‐Litvak P, Steinkampf MP, et al. Efficacy of superovulation and intrauterine insemination in the treatment of infertility. New England Journal of Medicine 1999;340(3):177‐83.

Kerin 1984 {published data only}

Kerin JFP, Peek J, Warnes GM, Kirby C, Jeffrey R, Matthews CD. Improved conception rate after intrauterine insemination of washed spermatozoa from men with poor quality semen. Lancet 1984;1:533‐5.

Melis 1995 {published data only}

Melis GB, Paoletti AM, Ajossa S, Guerriero S, Depau GF, Mais V. Ovulation induction with gonadotropins as sole treatment in infertile couples with open tubes: a randomized prospective comparison between intrauterine insemination and timed vaginal intercourse. Fertility & Sterility 1995;64:1088‐93.

Nan 1994 {published data only}

Nan PM, Cohlen BJ, te Velde ER, van Kooij RJ, Eimers JM, van Zonneveld P, et al. Intra‐uterine insemination or timed intercourse after ovarian stimulation for male subfertility? A controlled study. Human Reproduction 1994;9:2022‐6.

Aboulghar 1995 {published data only}

Aboulghar MA, Mansour RT, Serour GI, Amin YM. The role of intracytoplasmic sperm injection (ICSI) in the treatment of patients with borderline semen. Human Reproduction 1995;10(11):2829‐30.

Aboulghar 1996 {published data only}

Aboulghar MA, Mansour RT, Serour GI, Sattar MA, Amin YM. Intracytoplasmic sperm injection and conventional in vitro fertilization for sibling oocytes in cases of unexplained infertility and borderline semen. Journal of Assisted Reproduction and Genetics 1996;13(1):38‐42.

Agarwal 2004 {published data only}

Agarwal S, Mittal S. A randomised prospective trial of intrauterine insemination versus timed intercourse in superovulated cycles with clomiphene. Indian Journal of Medical Research 2004;6:519‐22.

Buvat 1990 {published data only}

Buvat J, Buvat‐Herbaut M, Marcolin G, Guittard C, Herbaut JC, Louvet AL, et al. Male subfertility: randomized comparison of intra‐uterine insemination versus timed intercourse after superovulation in the female. [Hypofertilite masculine: comparaison randomisee insemination intra‐uterine versus rapport sexuel programme apres superovulation de la femme]. Contraception Fertilite Sexualite 1990;18:435‐8.

Crosignani 1994 {published data only}

Crosignani PG, Walters DE. Clinical pregnancy and male subfertility; the ESHRE multicentre trial on the treatment of male subfertility. Human Reproduction 1994;9:1112‐8.

Cruz 1986 {published data only}

Cruz RI, Kemmann E, Brandeis VT, Becker KA, Beck M, Beardsley L, et al. A prospective study of intrauterine insemination of processed sperm from men with oligo‐astheno spermia in superovulated women. Fertility & Sterility 1986;46:673‐7.

Elizur 2004 {published data only}

Elizur SE, Levron J, Seidman DS, Kees S, Levran D, Dor J. Conventional in vitro fertilization versus intracytoplasmic sperm injection for sibling oocytes in couples with mild oligoteratoasthenozoospermia and couples with normal sperm. Fertility & Sterility 2004;82(1):241‐3.

Elzeiny 2014 {published data only}

Elzeiny H, Garrett C, Toledo M, Stern K, McBain J, Baker HWG. A randomised controlled trial of intra‐uterine insemination versus in vitro fertilisation in patients with idiopathic or mild male infertility. Australian and New Zealand Journal of Obstetrics and Gynaecology 2014;54:156‐61.

Evans 1991 {published data only}

Evans J, Wells C, Gregory L, Walker S. A comparison of intrauterine insemination, intraperitoneal insemination, and natural intercourse in superovulated women. Fertility & Sterility 1991;56:1183‐7.

Fan 2012 {published data only}

Fan W, Li SW, Li L, Huang Z, Ma Q, Wang Y, et al. Outcome of conventional IVF and ICSI on sibling oocytes in the case of isolated teratozoospermia. Journal of Assisted Reproduction and Genetics 2012;29:905‐10.

Fishel 2000 {published data only}

Fishel S, Aslam I, Lisi F, Rinaldi L, Timson J, Jacobson M, et al. Should ICSI be the treatment of choice for all cases of in‐vitro conception?. Human Reproduction 2000;15(6):1278‐83.

Friedman 1989 {published data only}

Friedman A, Haas S, Kredentser J, Stewart E, Schiff I. A controlled trial of intrauterine insemination for cervical factor and male factor: a preliminary report. International Journal of Fertility 1989;34:199‐203.

Galle 1990 {published data only}

Galle PC, McRae MA, Colliver JA, Alexander JS. Sperm washing and intrauterine insemination for cervical factor, oligospermia, immunological infertility and unexplained infertility. Journal of Reproductive Medicine 1990;35(2):116‐22.

Goverde 2001 {published data only}

Goverde AJ. IUI: the treatment of choice in idiopathic and male subfertility. Biomedical Pharmacotherapy 2001;55:70‐1.

Hewitt 1985 {published data only}

Hewitt J, Cohen J, Krishnaswamy V, Fehilly CB, Steptoe PC, Walters DE. Treatment of idiopathic infertility, cervical mucus hostility, and male infertility: artificial insemination with husband's semen or in vitro fertilization?. Fertility & Sterility 1985;44(3):350‐5.

Ho 1989 {published data only}

Ho PC, Poon IML, Chan SYW, Wang C. Intrauterine insemination is not useful in oligoasthenospermia. Fertility & Sterility 1989;51(4):682‐4.

Ho 1992 {published data only}

Ho PC, So WK, Chan YF, Yeung WSB. Intrauterine insemination after ovarian stimulation as a treatment for subfertility because of subnormal semen: a prospective randomized controlled trial. Fertility & Sterility 1992;58:995‐9.

Karlström 2000 {published data only}

Karlström PO, Bergh T, Lundkvist Ö. Addition of gonadotrophin‐releasing hormone agonist and/or two inseminations with husband's sperm do not improve the pregnancy rate in superovulated cycles. Acta Obstetricia et Gynaecologica Scandinavica 2000;79:37‐42.

Kastrop 1999 {published data only}

Kastrop PMM, Weima SM, van Kooij RJ, te Velde ER. Comparison between intracytoplasmic sperm injection and in‐vitro fertilization (IVF) with high insemination concentration after total fertilization failure in a previous IVF attempt. Human Reproduction 1999;14(1):65‐9.

Kihaile 2003 {published data only}

Kihaile PE, Misumi J, Hirotsuru K, Kumasako Y, Kisanga RE, Utsunomiya T. Comparison of sibling oocyte outcomes after intracytoplasmic sperm injection and in vitro fertilization in severe teratozoospermic patients in the first cycle. International Journal of Andrology 2003;26:57‐62.

Kirby 1991 {published data only}

Kirby CA, Flaherty SP, Godfrey BM, Warnes GM, Matthews CD. A prospective trial of intrauterine insemination of motile spermatozoa versus timed intercourse. Fertility & Sterility 1991;56:102‐7.

Li 2004 {published data only}

Li Z, Lin H, Xiao W, Wang Y. Fertilization of IVF/ICSI using sibling oocytes from couples with subfertile male or unexplained infertility. Journal of Huazhong University of Science and Technology 2004;24(4):365‐8.

Martinez 1991 {published data only}

Martinez AR, Bernardus RE, Voorhorst FJ, Vermeiden JP, Schoemaker J. Intrauterine insemination does and clomiphene citrate does not improve fecundity in couples with infertility due to male or idiopathic factors: a prospective, randomized, controlled study. Fertility & Sterility 1990;53(5):847‐53.
Martinez AR, Bernardus RE, Voorhorst FJ, Vermeiden JPW, Schoemaker J. Pregnancy rates after timed intercourse or intrauterine insemination after human menopausal gonadotropin stimulation or normal ovulatory cycles: a controlled study. Fertility & Sterility 1991;55:258‐65.

Melis 1987 {published data only}

Melis GB, Paoletti AM, Strigini F, Fabris FM, Canale D, Fioretti P. Pharmacologic induction of multiple follicular development improves the success rate of artificial insemination with husband's semen in couples with male‐related or unexplained infertility. Fertility & Sterility 1987;47(3):441‐5.

Moolenaar 2015 {published data only}

Moolenaar LM, Cissen M, de Bruin JP, Hompes PG, Repping S, van der Veen F, et al. Cost‐effectiveness of assisted conception for male subfertility. Reproductive Biomedicine Online 2015;30(6):659‐66.

Nulsen 1993 {published data only}

Nulsen JC, Walsh S, Dumez S, Metzger DA. A randomized and longitudinal study of human menopausal gonadotropin with intrauterine insemination in the treatment of infertility. Obstetrics and Gynecology 1993;82:780‐6.

Pisarska 1999 {published data only}

Pisarska MD, Casson PR, Cisneros PL, Lamb DJ, Lipshultz LI, Buster JE, et al. Fertilization after standard in vitro fertilization versus intracytoplasmic sperm injection in subfertile males using sibling oocytes. Fertility & Sterility 1999;71(4):627‐32.

Plachot 2002 {published data only}

Plachot M, Belaisch‐Allart J, Mayenga JM, Chouraqui A, Tesquier L, Serkine AM. Outcome of conventional IVF and ICSI on sibling oocytes in mild male factor infertility. Human Reproduction 2002;17(3):362‐9.

Prentice 1995 {published data only}

Prentice A, Sacks GP, Morton NC, Deary AJ, Smith SK. Controlled ovarian stimulation (superovulation) and intrauterine insemination for the treatment of unexplained and minor male factor infertility. Human Reproduction 1995;10(Abstract book 2):112.

Soliman 1993 {published data only}

Soliman S, Daya S, Collins J, Jarrell J. A randomized trial of in vitro fertilization versus conventional treatment for infertility. Fertility & Sterility 1993;59(6):1239‐44.

te Velde 1989 {published data only}

te Velde ER, van Kooy RJ, Waterreus JJH. Intrauterine insemination of washed husband's spermatozoa: a controlled study. Fertility & Sterility 1989;51:182‐5.

Tournaye 2002 {published data only}

Tournaye H, Verheyen G, Albano C, Camus M, van Landuyt L, Devroey P, et al. Intracytoplasmic sperm injection versus in vitro fertilization: a randomized controlled trial and a meta‐analysis of the literature. Fertility & Sterility 2002;78(5):1030‐7.

van der Westerlaken 2006 {published data only}

van der Westerlaken L, Naaktgeboren N, Verburg H, Dieben S, Helmerhorst FM. Conventional in vitro fertilization versus intracytoplasmic sperm injection in patients with borderline semen: a randomized study using sibling oocytes. Fertility & Sterility 2006;85(2):395‐400.

Verheyen 1999 {published data only}

Verheyen G, Tournaye H, Staessen C, de Vos A, Vandervorst M, van Steirteghem A. Controlled comparison of conventional in‐vitro fertilization and intracytoplasmic sperm injection in patients with asthenozoospermia. Human Reproduction 1999;14(9):2313‐9.

Xie 2015 {published data only}

Xie BG, Huang YH, Zhu WJ, Jin S. Comparison of the outcome of conventional in vitro fertilization and intracytoplasmic sperm injection in moderate male infertility from ejaculate. Urologia Internationalis 2015;94(1):111‐6.

Zayed 1997 {published data only}

Zayed F, Lenton EA, Cooke ID. Comparison between stimulated in‐vitro fertilization and stimulated intrauterine insemination for the treatment of unexplained and mild male factor infertility. Human Reproduction 1997;12(11):2408‐13.

References to studies awaiting assessment

Aribarg 1995 {published data only}

Aribarg A, Sukcharoen N. Intrauterine insemination of washed spermatozoa for treatment of oligozoospermia. International Journal of Andrology 1995;18(Suppl 1):62‐6.

Jaroudi 1998 {published data only}

Jaroudi KA, Hollanders H, Sieck U, Zahrani A, Al‐Nour A, Atared A. Superovulation and intrauterine insemination for male factor infertility: a controlled randomized study. Middle East Fertility Society Journal 1998;3(3):254‐9.

Kerin 1987 {published data only}

Kerin J, Quinn P. Washed intrauterine insemination in the treatment of oligospermic infertility. Seminars in Reproductive Endocrinology 1987;5:23‐33.

Andersen 1995

Andersen AG, Als‐Nielsen BM, Hornenes PJ, Franch Andersen L. Time interval from human chorionic gonadotrophin (HCG) injection to follicular rupture. Human Reproduction 1995;10:3202‐5.

Avendano 2010

Avendano C, Franchi A, Duran H, Oehninger S. DNA fragmentation of normal spermatozoa negatively impacts embryo quality and intracytoplasmic sperm injection outcome. Fertility & Sterility 2010;94(2):549‐57.

Bakos 2008

Bakos HW, Thompson JG, Feil D, Lane M. Sperm DNA damage is associated with assisted reproductive technology pregnancy. International Journal of Andrology 2008;31(5):518‐26.

Bensdorp 2009

Bensdorp AJ, Slappendel E, Koks C, Oosterhuis J, Hoek A, Hompes P, et al. The INeS study: prevention of multiple pregnancies: a randomised controlled trial comparing IUI COH versus IVF e SET versus MNC IVF in couples with unexplained or mild male subfertility. BMC Women's Health 2009;9(35):1‐8.

Bhattachary 2000

Bhattachary S. Cost‐effective treatment of couples with subfertility. Lancet 2000;355(1):2.

Bhattachary 2001

Bhattacharya S, Hamilton MP, Shaaban M, Khalaf Y, Seddler M, Ghobara T, et al. Conventional in‐vitro fertilisation vs intracytoplasmic sperm injection for the treatment of non‐male‐factor infertility: a randomised controlled trial. Lancet 2001;357(9274):2075‐9.

Boomsma 2007

Boomsma CM, Heineman MJ, Cohlen BJ, Farquhar C. Semen preparation techniques for intrauterine insemination. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD004507.pub3]

Boulet 2015

Boulet SL, Mehta A, Kissin DM, Warner L, Kawwass JF, Jamieson DJ. Trends in use of and reproductive outcomes associated with intracytoplasmic sperm injection. JAMA 2015;313(3):255‐63.

Cantineau 2007

Cantineau AEP, Cohlen BJ. Ovarian stimulation protocols (anti‐oestrogens, gonadotrophins with and without GnRH agonists/ antagonists) for intrauterine insemination (IUI) in women with subfertility. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD005356.pub2]

Cohen 1984

Cohen J, Fehilly CB, Fishel SB, Edwards RG, Hewitt J, Rowland GF, et al. Male infertility successfully treated by in‐vitro fertilisation. Lancet 1984;8388:1239‐40.

Cohlen 1998b

Cohlen BJ, te Velde ER, Looman CW, Eijckemans R, Habbema JD. Crossover or parallel design in infertility trials? The discussion continues. Fertility & Sterility 1998;70(1):40‐5.

Cohlen 2005

Cohlen BJ. Should we continue performing intrauterine inseminations in the year 2004?. Gynecologic and Obstetric Investigation 2005;59(1):3‐13.

Cooper 2010

Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HW, Behre HM, et al. World Health Organization reference values for human semen characteristics. Human Reproduction Update 2010;16(3):231‐45.

Coppus 2007

Coppus SF, Verhoeve HR, Opmeer BC, van der Steeg JW, Steures P, Eijkemans MJ, et al. Identifying subfertile ovulatory women for timely tubal patency testing: a clinical decision rule based on medical history. Human Reproduction 2007;22(10):2685‐92.

Dias 2006

Dias S, McNamee R, Vail A. Evidence of improving quality of reporting of randomized controlled trials in subfertility. Human Reproduction 2006;10:2617‐27.

Dickey 1999

Dickey RP, Pyrzak R, Lu PY, Taylor SN, Rye PH. Comparison of the sperm quality necessary for successful intrauterine insemination with World Health Organization threshold values for normal sperm. Fertility & Sterility 1999;17:684‐9.

Duran 2002a

Duran EH, Morshedi M, Taylor S, Oehninger S. Sperm DNA quality predicts intrauterine insemination outcome: a prospective cohort study. Human Reproduction 2002;17:3122‐8.

Duran 2002b

Duran HE, Morshedi M, Kruger T, Oehninger S. Intrauterine insemination: a systematic review on determinants of success. Human Reproduction Update 2002;8(4):373‐84.

Elbourne 2002

Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV. Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology 2002;31:140‐9.

Fauser 2005

Fauser BCJM, Devroey P, Macklon NS. Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet 2005;365:1807‐16.

Guzick 1998

Guzick DS, Sullivan MW, Adamson GD, Cedars MI, Falk RJ, Peterson EP, et al. Efficacy of treatment for unexplained infertility. Fertility & Sterility 1998;70(2):207‐13.

Hamilton 2015

Hamilton JA, Cissen M, Brandes M, Smeenk JMJ, de Bruin JP, Kremer JA, et al. Total motile sperm count: a better indicator for the severity of male factor infertility than the WHO sperm classification system. Human Reproduction 2015;30(5):1110‐21.

Healy 2004

Healy D. Damaged babies from assisted reproductive technologies: focus on BESST (birth emphasizing a successful singleton at term) outcome. Fertility & Sterility 2004;3:512‐3.

Higgins 2011

Higgins JPT, Greens S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Hoff 1983

Hoff JD, Quigley ME, Yen SS. Hormonal dynamics at midcycle: a reevaluation. Journal of Clinical Endocrinology and Metabolism 1983;4:792‐6.

Hull 1985

Hull MGR, Glazener CMA, Kelly NJ, Conway DI, Foster PA, Hinton RA, et al. Population study of causes, treatment and outcome of infertility. British Medical Journal 1985;291:1693‐7.

Hunault 2004

Hunault C, Habbema JD, Eijkemans MJ, Collins JA, Evers JL, te Velde ER. Two new prediction rules for spontaneous pregnancy leading to live birth among subfertile couples, based on the synthesis of three previous models. Human Reproduction 2004;19:2019‐26.

Johnson 2003

Johnson NP, Proctor M, Farquhar CM. Gaps in the evidence for fertility treatment ‐ an analysis of the Cochrane Menstrual Disorders and Subfertility Group database. Human Reproduction 2003;18(5):947‐54.

Khan 1996

Khan KS, Daya S, Collins JA, Walter SD. Empirical evidence of bias in infertility research: overestimation of treatment effect in crossover trials using pregnancy as the outcome measure. Fertility & Sterility 1996;65:939‐45.

Kim 2007

Kim HH, Bundorf MK, Behr B, McCallum SW. Use and outcomes of intracytoplasmic sperm injection for non‐male factor infertility. Fertility & Sterility 2007;88(3):622‐8.

Kruger 1993

Kruger TF, Du Toit TC, Franken DR, Acosta AA, Oehninger SC, Menkveld R, et al. A new computerized method of reading sperm morphology (strict criteria) is as efficient as technician reading. Fertility & Sterility 1993;59(1):202‐9.

Mansour 2014

Mansour R, Ishihara O, Adamson GD, Dyer S, de Mouzon J, Nygren KG, et al. International Committee for Monitoring Assisted Reproductive Technologies world report: assisted reproductive technology 2006. Human Reproduction 2014;29:1536‐51.

Matorras 1995

Matorras R, Corcostequi B, Perez C, Mandiola M, Mendoza R, Rodriguez‐Escudero FJ. Sperm morphology analysis (strict criteria) in male infertility is not a prognostic factor in intrauterine insemination with husband's sperm. Fertility & Sterility 1995;63(3):608‐11.

McDonnell 2004

McDonnell J, Goverde AJ, Vermeiden JPW. The place of the crossover design in infertility trials: a maximum likelihood approach. Human Reproduction 2004;19(11):2537‐44.

Mochtar 2011

Mochtar MH, Custers IM, Koks CA, Bernardus RE, Verhoeve HR, Mol BW, et al. Timing oocyte collection in GnRH agonists down‐regulated IVF and ICSI cycles: a randomized clinical trial. Human Reproduction 2011;26(5):1091‐6.

NICE 2013

National Institute for Health and Care Excellence. Fertility problems: assessment and treatment for people with fertility problems. Clinical guideline published by the RCOG press2013; Vol. 156, issue https://www.nice.org.uk/guidance/cg156.

Norman 2000

Norman GR, Daya S. The alternating‐sequence design (or multiple‐period crossover) trial for evaluating treatment efficacy in infertility. Fertility & Sterility 2000;74(2):319‐24.

Ombelet 1997

Ombelet W, Vandeput H, Janssen M, Cox A, Vossen C, Pollet H, et al. Treatment of male infertility due to sperm surface antibodies: IUI or IVF. Human Reproduction 1997;12(6):1165‐70.

Ombelet 2003

Ombelet W. Semen quality and intrauterine insemination. Reproductive BioMedicine Online 2003;7(4):465‐92.

Palermo 1992

Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet 1992;340:17‐8.

Pandian 2012

Pandian Z, Gibreel A, Bhattacharya S. In vitro fertilisation for unexplained subfertility. Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD003357.pub3]

Practice Committee of the ASRM 2012

Practice Committee of the American Society for Reproductive Medicine. Multiple gestation associated with infertility therapy: an American Society for Reproductive Medicine Practice Committee opinion. Fertility & Sterility 2012;97:825‐34.

Practice Committee of the ASRM 2013

Practice Committee of the American Society for Reproductive Medicine. The clinical utility of sperm DNA integrity testing: a guideline. Fertility & Sterility 2013;99:673‐7.

Repping 2002

Repping S, van Weert JM, Mol BWJ, de Vries JWA, van der Veen F. Use of the total motile sperm count to predict total fertilization failure in in vitro fertilization. Fertility & Sterility 2002;78(1):22‐8.

RevMan 2014 [Computer program]

The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

Rhemrev 2001

Rhemrev JPT, Lens JW, McDonnell J, Schoemaker J, Vermeiden JPW. The postwash total progressively motile sperm cell count is a reliable predictor of total fertilization failure during in vitro fertilization treatment. Fertility & Sterility 2001;76(5):884‐91.

Simon 2014

Simon L, Liu L, Murphy K, Ge S, Hotaling J, Aston KI, et al. Comparative analysis of three sperm DNA damage assays and sperm nuclear protein content in couples undergoing assisted reproduction treatment. Human Reproduction 2014;29(5):904‐17.

Steures 2004

Steures P, van der Steeg JW, Mol BW, Eijkemans MJ, van der Veen F, Habbema JD, et al. Prediction of an ongoing pregnancy after intrauterine insemination. Fertility & Sterility 2004;82(1):45‐51.

Steures 2006

Steures P, van der Steeg JW, Hompes PGA, Habbema DF, Eijkemans MJC, Broekmans FJ, et al. Intrauterine insemination with controlled ovarian hyperstimulation versus expectant management for couples with unexplained subfertility and an intermediate prognosis: a randomised clinical trial. Lancet 2006;368:216‐21.

Sullivan 2013

Sullivan EA, Zegers‐Hochschild F, Mansour R, Ishihara O, de Mouzon J, Nygren KG, et al. International Committee for Monitoring Assisted Reproductive Technologies (ICMART) world report: assisted reproductive technology 2004. Human Reproduction 2013;28:1375‐90.

Tarlatzis 2006

Tarlatzis BC, Fauser BC, Kolibianakis EM, Diedrich K, Rombauts L, Devroey P. GnRH antagonists in ovarian stimulation for IVF. Human Reproduction Update 2006;12(4):333‐40.

Testart 1982

Testart J, Frydman R. Minimum time lapse between luteinizing hormone surge or human chorionic gonadotrophin administration and follicular rupture. Fertility & Sterility 1982;37:50.

Tijani 2010

Tijani HA, Bhattacharya S. The role of intrauterine insemination in male infertility. Human Fertility 2010;13:226‐32.

Tjon‐Kon‐Fat 2015

Tjon‐Kon‐Fat RI, Bensdorp AJ, Bossuyt PM, Koks C, Oosterhuis GJ, Hoek A, et al. Is IVF‐served two different ways‐more cost‐effective than IUI with controlled ovarian hyperstimulation?. Human Reproduction 2015;30(10):2331‐9.

Tournaye 2012

Tournaye H. Male factor infertility and ART. Asian Journal of Andrology 2012;14:103‐8.

Vail 2003

Vail A, Gardener E. Common statistical errors in the design and analysis of subfertility trials. Human Reproduction 2003;18(5):1000‐4.

van der Steeg 2011

van der Steeg JW, Steures P, Eijkemans MJC, Habbema JD, Hompes PG, Kremer JAM, et al. Role of semen analysis in subfertile couples. Fertility & Sterility 2011;95(3):1013‐9.

van der Westenlaken 2005

van der Westenlaken L, Helmerhorst F, Dieben S, Naaktgeboren N. Intracytoplasmic sperm injection as a treatment for unexplained total fertilization failure or low fertilization after conventional in vitro fertilization. Fertility & Sterility 2005;83:612‐7.

van Voorhis 2001

van Voorhis BJ, Barnett M, Sparks AET, Syrop CH, Rosenthal G, Dawson J. Effect of the total motile sperm count on the efficacy and cost‐effectiveness of intrauterine insemination and in vitro fertilization. Fertility & Sterility 2001;75(4):661‐8.

van Weert 2004

van Weert J‐M, Repping S, Van Voorhis BJ, van der Veen F, Bossuyt PMM, Mol BWJ. Performance of the postwash total motile sperm count as a predictor of pregnancy at the time of intrauterine insemination: a meta‐analysis. Fertility & Sterility 2004;82(3):612‐20.

Veltman‐Verhulst 2012

Veltman‐Verhulst SM, Cohlen BJ, Hughes E, Heineman MJ, Te Velde E. Intra‐uterine insemination for unexplained subfertility. Cochrane Database of Systematic Reviews 2012, Issue 9. [DOI: 10.1002/14651858.CD001838.pub4]

Verhoeve 2006

Verhoeve HR, van der Veen F, Mol BW. Diagnostic tests in reproductive medicine. Reviews in Gynaecological and Perinatal Practice 2006;6:20‐5.

Wainer 2004

Wainer R, Albert M, Dorion A, Bailly M, Bergere M, Lombroso R, et al. Influence of the number of motile spermatozoa inseminated and of their morphology on the success of intrauterine insemination. Human Reproduction 2004;9:2060‐5.

WHO 1980

World Health Organization Task Force Investigators. Temporal relationships between ovulation and defined changes in the concentration of plasma estradiol‐17 beta, luteinizing hormone, follicle stimulating hormone and progesterone. American Journal of Obstetrics and Gynecology 1980;138(4):382‐90.

WHO 1987

World Health Organization. Laboratory Manual for Semen Analysis and Sperm Cervical Mucus Interaction, revised edition. London/New York: Cambridge University Press, 1987.

WHO 1992

World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Sperm Cervical Mucus Interaction. Cambridge: Cambridge University Press, 1992.

WHO 2010

World Health Organization. WHO Manual for the Examination and Processing of Human Semen. Geneva: World Health Organization, 2010.

Zikopoulos 2005

Zikopoulos K, Kaponis A, Adonakis G, Sotiriadis A, Kalantaridou S, Georgiou I, et al. A prospective randomized study comparing gonadotropin‐releasing hormone agonists or gonadotropin‐releasing hormone antagonists in couples with unexplained infertility and/or mild oligozoospermia. Fertility & Sterility 2005;83(5):1354‐62.

References to other published versions of this review

Bensdorp 2007a

Bensdorp A, Cohlen BJ, Heineman MJ, Vanderkerckhove P. Intra‐uterine insemination for male subfertility. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD000360.pub3]

Bensdorp 2007b

Bensdorp A, Cohlen BJ, Heineman MJ, Vanderkerckhove P. Intra‐uterine insemination for male subfertility. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD000360.pub4]

Cohlen 1998

Cohlen BJ, Vanderkerckhove P, Te Velde ER, Habbema JDF. Timed intercourse versus intra‐uterine insemination with or without ovarian hyperstimulation for subfertility in men. Cochrane Database of Systematic Reviews 1998, Issue 1. [DOI: 10.1002/14651858.CD000360]

Cohlen 2000

Cohlen BJ, Vanderkerckhove P, te Velde ER, Habbema JDF. Timed intercourse versus intra‐uterine insemination with or without ovarian hyperstimulation for subfertility in men. Cochrane Database of Systematic Reviews 2000, Issue 2. [DOI: 10.1002/14651858.CD000360.pub2]

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Arici 1994

Methods

Design: cross‐over alternating

Pre‐cross‐over data: available

Power calculation: not stated

ITT: no ITT

Number of couples randomised: 75

Number of couples analysed: 56

Number of couples included in this review: 30

Number of started cycles: not stated

Number of completed cycles: 95

Number of drop‐outs: 17 before starting first treatment cycles (failed to return (n = 9), refused randomisation (n = 5), other subfertility factors (n = 3)) and 27 during the study (moved out of the geographical area (n = 3), failed to return (n = 6), cross‐over (n = 18)). 2 couples became pregnant before the initiation of the first treatment cycle

Number of cancelled cycles: not stated

Centre: single‐centre, private infertility practice of the University of Texas, Southwestern Medical Center at Dallas, TX, USA

Participants

Couples: male (n = 26) and unexplained (n = 30) subfertility

Definition male subfertility: sperm concentration < 20 million/mL, total motility < 50%, normal morphology < 50%, or a combination of these (WHO 1987)

Number of semen samples: 2

Age of women (whole group): mean 33 years (range 24‐41)

Duration of subfertility: mean 3.5 years (range 2.4‐5.5)

Primary/secondary subfertility: not stated

Ovulatory status: BBT, luteal progesterone > 10 ng/mL or in‐phase late luteal endometrial biopsy

Tubal patency: DLS, HSG, or both

PCT: not stated

Previous treatment: endocrinologically/surgically correctable factors were treated, no previous ART

Exclusion criteria: sperm antibodies

Interventions

Comparison: IUI with OH cycles vs. IUI in natural cycles

Treatment duration: maximum of 4 cycles

Method OH: CC 50 mg days 5‐9

Timing ovulation for IUI in natural cycles: LH surge urine

Timing ovulation for IUI + OH cycles: measurement follicles > 18 mm

Ovulation induction (IUI + OH cycles): hCG 10,000 IM when ≥ 1 follicles 18 mm

Number of IUI per cycle: 1 or 2

Timing IUI in natural cycles: first on day of LH peak, a second next day when possible

Timing IUI + OH cycles: single IUI 32 hours after injection

Sperm preparation: wash (human tubal fluid) and centrifugation

Number of inseminated spermatozoa: not stated

Cancellation criteria: women exhibiting an anovulatory cycle at any time during the study

Outcomes

PR per couple for the first cycle, PR per completed cycle

OHSS: not stated

Miscarriage rate: not stated

Multiple PR: not stated

Ectopic PR: not stated

Definition/diagnosis pregnancy: gestational sac confirmed by USS

Notes

Large number of drop‐outs. Authors supplied unpublished pre‐cross‐over data. No stratification by diagnosis category of subfertility, unequal division of couples between treatment options

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Computer‐generated random numbers table

Allocation concealment (selection bias)

Unclear risk

Unclear

Blinding (performance bias and detection bias)
All outcomes

Low risk

No blinding stated, but outcome was not likely to be influenced

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Less than 95% of the couples included in analysis

Selective reporting (reporting bias)

Unclear risk

No protocol available, adverse effects not stated

Other bias

High risk

Cross‐over design

Bensdorp 2015

Methods

Design: parallel study

Power calculation (for whole group): stated

ITT: done

Number of couples randomised: 602 (male subfertility, n = 57)

Number of couples analysed: 602 (male subfertility, n = 57)

Number of couples included in this review: 36

Number of started cycles: 104

Number of completed cycles: 97

Number of drop‐outs: 4 (personal reasons (n = 2), medical reasons (n = 2))

Number of cancelled cycles: 7 (no embryo transfer (n = 4), no IUI (n = 3))

Centre: multicentre, 17 centres, the Netherlands

Participants

Couples: unexplained (n = 545) and mild male (n = 57) subfertility

Definition male subfertility: pre‐wash TMSC 3‐10 million

Number of semen samples: not stated

Mean age of women (whole group): IUI + OH 34 years (SD ± 3.67), IVF‐SET 33 years (SD ± 3.39), IVF‐MNC 33 years (SD ± 3.50)

Duration of subfertility (mean (IQR) for whole group): IUI + OH 2.30 years (1.82‐3.13), IVF‐SET 2.13 years (1.73‐3.01), IVF‐MNC 2.14 years (1.77‐2.81)

Primary/secondary subfertility: mixed

Ovulatory status: done

Tubal patency: chlamydia antibody test, HSG or DLS

PCT: not stated

Previous treatment: none

Exclusion criteria: anovulation, double‐sided tubal disease, severe endometriosis, premature ovarian failure and endocrine disorders

Interventions

Comparison: IVF‐SET (n = 18) vs. IVF‐MNC (n = 21) vs. IUI in cycles with OH (n = 18)

Treatment duration: maximum 12 months (3 cycles of IVF‐SET plus subsequent cryo cycles, 6 cycles of IVF‐MNC or 6 cycles of IUI with COH)

Method OH for IVF‐SET: long or short agonist or antagonist protocol (adhere to local stimulation protocols), COH using FSH 150 IU

Method OH for IVF‐MNC: daily injections of GnRH antagonist 0.25 mg and FSH 150 IU when the leading follicle had a diameter of ≥ 14 mm

Method OH for IUI: CC 100 mg (cycle day 3‐7) or FSH 75 IU (daily)

Timing ovulation for IVF‐SET: measurement of ≥ 2 follicles of ≥ 18 mm

Timing ovulation for IVF‐MNC: measurement of a follicle of 17‐18 mm

Timing ovulation for IUI + OH cycles: measurement of at least 1 follicle of 17‐18 mm

Ovulation induction for IVF: hCG 10,000 IU

Ovulation induction for IUI + OH cycles: hCG 5000 IU

Number of IUI per cycle: 1

Timing IUI + OH cycles: 36 hours after hCG

Semen preparation: not stated

Number of inseminated spermatozoa: not stated

Embryo transfer: 2‐4 days after oocyte retrieval

1 good‐quality embryo or 2 embryos if no good embryos were available

After results of pilot study only SET

Luteal phase support (IVF): hCG 1500 IU on day 5, 8 and 11 after oocyte retrieval

Cancellation criteria IUI: OHSS (> 3 follicles ≥ 16 mm or > 5 follicles > 12 mm)

Cancellation criteria IVF: not stated

Outcomes

Live birth and PR per couple

OHSS: stated

Miscarriage rate: stated

Multiple PR: stated

Ectopic PR: not stated

Definition/diagnosis pregnancy: confirmed by USS

Notes

Power calculation: 200 couples were needed per treatment group to obtain an 80% power to detect a difference of 12.5% between IUI with COH and IVF‐SET

Inclusion criteria: women aged 18‐38 years, an unfavourable prognosis for natural conception (Hunault < 30%) and diagnosis of unexplained or mild male subfertility. Author supplied separate data for male subfertility. No stratification by diagnosis category of subfertility

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

A web‐based generated program

Allocation concealment (selection bias)

Low risk

Unique numbers with allocation code

Blinding (performance bias and detection bias)
All outcomes

Low risk

No blinding stated, but outcome was not likely to be influenced

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Complete outcome data

Selective reporting (reporting bias)

Low risk

Protocol available (Bensdorp 2009)

Other bias

Low risk

No other bias

Cohlen 1998a

Methods

Design: cross‐over alternating

Pre‐cross‐over data: available

Power Calculation: stated

ITT: done

Number of couples randomised: 74

Number of couples analysed: 74

Number of couples included in this review: 74

Number of started cycles: 320

Number of completed cycles: 308

Number of drop‐outs: 6 (personal reasons)

Number of cancelled cycles: 12 (premature or missed LH surge (n = 7), OHSS (n = 5))

Centre: single centre, Utrecht, the Netherlands

Participants

Couples: male subfertility

Definition male subfertility: concentration < 20 million/mL, motility < 40%, normal morphology < 40%, or a combination of these

Number of semen samples: ≥ 2

Age of women: 30.7 years (range 24‐39)

Duration of subfertility: 3.1 years (range 2‐9)

Primary/secondary subfertility: mixed

Ovulatory status: BBT and luteal progesterone > 9.7 ng/mL

Tubal patency: HSG, DLS, or both

PCT: done

Previous treatment: not stated

Exclusion criteria: sperm antibodies, cervical factor

Interventions

Comparison: IUI with OH cycles vs. IUI in natural cycles

Treatment duration: maximum 6 cycles

Method OH: HMG 75 IU/day up to HMG 150 IU/day starting on cycle day 3

Timing ovulation for IUI in natural cycles: LH surge blood

Timing ovulation for IUI + OH cycles: measurement follicles ≥ 18 mm or LH surge blood

Ovulation induction (IUI + OH cycles): hCG 5000 IU

Number of IUI per cycle: 1

Timing IUI in natural cycles: 26 hours after LH surge

Timing IUI + OH cycles: 38‐40 hours after hCG

Sperm preparation: wash (Ham's F10) and Percoll

Number of inseminated spermatozoa: no conception observed below threshold of < 1 million motile spermatozoa

Cancellation criteria: ≥ 4 follicles ≥ 18 mm or oestradiol > 1635 pg/mL, premature LH surge, no LH surge detected

Outcomes

PR and live birth rate per started and completed cycle

OHSS rate: stated

Miscarriage rate: stated

Multiple PR: stated

Ectopic PR: not stated

Definition/diagnosis pregnancy: hCG in urine + USS at 6‐7 weeks

Notes

Power calculation: 150 cycles per treatment would be needed to detect an 8% difference (numbers based on previous studies) between natural cycles vs. stimulated cycles

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Not stated

Allocation concealment (selection bias)

Low risk

Opaque sealed envelopes

Blinding (performance bias and detection bias)
All outcomes

Low risk

No blinding stated, but outcome was not likely to be influenced

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Complete outcome data, adequate description of drop‐outs

Selective reporting (reporting bias)

Unclear risk

No protocol available

Other bias

High risk

Cross‐over design

Francavilla 2009

Methods

Design: cross‐over alternating

Pre‐cross‐over data: not stated

Power calculation: stated

ITT: not stated

Number of couples randomised: not stated

Number of couples analysed: 73

Number of couples included in this review: 63

Number of started cycles: 384

Number of completed cycles: 384

Number of drop‐outs: not stated

Number of cancelled cycles: none

Centre: single centre, L'Aquila, Italy

Participants

Couples: male subfertility (OAT) (n = 63), immunological subfertility (n = 10)

Definition male subfertility: motile sperm count < 10 million/mL (due to oligozoospermia (< 20 million/mL), asthenozoospermia (< 50% progressive motility)), teratozoospermia (normal sperm morphology < 15%), immunological subfertility, or a combination of these

Number of semen samples: ≥ 2

Age of women: ≤ 40 years

Duration of subfertility: ≥ 2 years

Primary/secondary subfertility: primary

Ovulatory status: mid‐luteal phase progesterone ≥ 10 ng/mL, day 3 FSH < 10 IU/mL

Tubal patency: HSG, DLS, or both

PCT: done

Previous treatment: not stated

Exclusion criteria: < 1 million motile spermatozoa after semen preparation

Interventions

Comparison: TI in natural cycles vs. IUI with OH cycles vs. IUI in natural cycles

Treatment duration: maximum 9 cycles (6 IUI cycles)

Method OH: CC 50 mg/day (cycle day 3‐7) and hMG 75 IU/day (cycle day 8 and 9)

Timing of ovulation: LH surge urine or measurement of at least 1 follicle ≥ 20 mm when no LH surge was detected

Ovulation induction (when no LH surge was detected): hCG 10,000 IU

Number of IUI per cycle: 1 or 2

Timing IUI: the day after LH surge and in 2 consecutive days if the LH surge was detected in the evening or 39‐41 hours after hCG

Timing intercourse: the day after LH surge

Sperm preparation: swim up procedure

Number of inseminated spermatozoa: not stated

Cancellation criteria: not stated

Outcomes

PR per completed cycle, authors supplied live birth rates per completed cycle

OHSS: stated

Miscarriage rate: stated

Multiple PR: stated

Ectopic PR: not stated

Definition/diagnosis pregnancy: intrauterine gestational sac detected by USS

Notes

Authors supplied unpublished pre‐cross‐over data. No stratification by diagnosis category of subfertility (male subfertility and immunological subfertility)

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Not stated

Allocation concealment (selection bias)

High risk

On chronological basis

Blinding (performance bias and detection bias)
All outcomes

Low risk

No blinding stated, but outcome was not likely to be influenced

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Authors supplied unpublished pre‐cross‐over data

Selective reporting (reporting bias)

Unclear risk

No protocol available

Other bias

High risk

Cross‐over design

Goverde 2000

Methods

Design: parallel study

Power calculation (for whole group): stated

ITT: done

Number of couples randomised: 258

Number of couples analysed: 258

Number of couples included in this review: 77

Number of started cycles: 963 (male subfertility = 293)

Number of completed cycles: 184

Number of drop‐outs (whole group): > 10%

Number of cancelled cycles (whole group): > 10%

Centre: single centre, Vrije Universitieit Medical Centre, Amsterdam, the Netherlands

Participants

Couples: male (n = 77) and unexplained (n = 179) subfertility

Definition male subfertility: TMSC of < 20 million progressively motile sperm

Number of semen samples: 3 out of 5

Mean age of women (only male subfertility): IUI + OH 31.7 years (SD ± 3.92), IUI in natural cycle 31.6 years (SD ± 3.73), IVF 32.1 years (SD ± 4.20)

Duration of subfertility (only male subfertility): IUI + OH 4.2 years (SD ± 1.9), IUI in natural cycle 3.9 years (SD ± 1.7), IVF 4.5 years (SD ± 2.8)

Primary/secondary subfertility: mixed

Ovulatory status: BBT, endometrial biopsy

Tubal patency: DLS + HSG

PCT: done

Previous treatment: not stated

Exclusion criteria: cycle disorders, untreated endometriosis, bilateral occluded tubes or semen sample yielded < 1 million progressively motile spermatozoa after processing, > 20% carried antibodies or > 50% had no acrosome

Interventions

Comparison: IUI with OH cycles vs. IUI in natural cycles vs. IVF

Treatment duration: maximum 6 cycles

Method OH for IUI: FSH 75 IU (starting dose)

Method OH for IVF: women < 38 years: 'long' protocol: GnRH agonist and FSH or hMG 150‐225 IU; women > 38 years: 'short' protocol

Timing ovulation for IUI in natural cycles: LH surge urine

Timing ovulation for IUI + OH cycles: measurement 1‐3 follicles > 18 mm or LH surge urine

Timing ovulation for IVF: measurement at least 1 follicle > 18 mm and 3 follicles > 16 mm

Ovulation induction (IUI + OH cycles and IVF): hCG 10,000 IU

Number of IUI per cycle: 1

Timing IUI in natural cycles: 20‐30 hours after LH surge

Timing IUI + OH cycles: 20‐30 hours after LH surge, 40‐42 hours after hCG when no LH surge was detected

Semen preparation: Percoll gradient technique

Number of inseminated spermatozoa: not stated

Embryo transfer: 48‐72 hours after oocyte retrieval: women ≤ 35 years: maximum 2 embryos; women > 35 years: maximum 3 embryos

Luteal phase support (IVF): 3 doses of progesterone 200 mg/day intravaginally, in case of breakthrough bleeding hCG 1500 IU every 48 hour

Cancellation criteria IUI: > 3 follicles of ≥ 18 mm or > 6 follicles of ≥ 14 mm

Cancellation criteria IVF: serum oestradiol > 20,000 nmol/L

Outcomes

Live birth rate per couple (PR include only pregnancies that resulted in at least 1 live birth)

OHSS: stated

Miscarriage rate: not stated

Multiple PR: stated

Ectopic PR: not stated

Definition/diagnosis pregnancy: LH urine and USS confirmation

Notes

Power calculation: 80 couples were needed per treatment group to obtain a 90% power to detect a difference of 9% between IUI and IVF. Stratification for woman's age, duration of subfertility, diagnosis, category of subfertility, presence of either 1 or 2 ovaries

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Computer‐generated randomisation schedule

Allocation concealment (selection bias)

Low risk

Numbered masked and sealed envelopes

Blinding (performance bias and detection bias)
All outcomes

Low risk

No blinding stated, but outcome was not likely to be influenced

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Complete outcome data, adequate description of drop‐outs/cancellations

Selective reporting (reporting bias)

Unclear risk

No protocol available

Other bias

Low risk

No other bias

Gregoriou 1996

Methods

Design: cross‐over after 3 cycles

Pre‐cross‐over data: available

Power calculation: not stated

ITT: not stated

Number of couples randomised: 62

Number of couples analysed: 62

Number of couples included in this review: 62

Number of started cycles: 314, before cross‐over 172

Number of completed cycles: 258, before cross‐over 143

Number of drop‐outs: not stated

Number of cancelled cycles: 56

Centre: single centre, Athens, Greece

Participants

Couples: male subfertility

Definition male subfertility: sperm concentration < 20 million/mL, progressive motility < 30%, normal morphology < 40%, or a combination of these

Number of semen samples: 3

Age of women: mean 30.5 years (SD ± 2.6)

Duration of subfertility: mean 5.8 years (SD ± 3.9)

Primary/secondary subfertility: mixed

Ovulatory status: BBT, luteal progesterone ≥ 32 nmol/L and in‐phase endometrial biopsy

Tubal patency: HSG and DLS

PCT: not stated

Previous treatment: not stated

Exclusion criteria: abnormal serum levels of testosterone, dehydroepiandrosterone‐sulphate, prolactin or thyroid‐stimulating hormone in women

Interventions

Comparison: IUI with OH cycles vs. TI with OH

Treatment duration: maximum 6 cycles

Method OH: day 3‐9 hMG 75 IU/day, if no increase in serum oestradiol was observed, dose increased to hMG 150 IU/day for next 5 days

Timing ovulation: measurement of follicle > 16 mm and oestradiol ≤ 5500 pmol/L, 24 hours after last hMG

Ovulation induction: hCG 10,000 IU

Number of IUI per cycle: 1

Timing IUI: 36‐40 hours after hCG administration

Timing intercourse: 36‐40 hours after hCG administration

Sperm preparation: wash (Ham's 10) 2‐layer Percoll gradient (40% and 90%)

Number of inseminated spermatozoa: not stated

Cancellation criteria: OH

Outcomes

PR per completed and per started cycle

OHSS: not stated

Miscarriage: not stated

Multiple PR: not stated

Ectopic PR: not stated

Definition/diagnosis pregnancy: hCG serum and gestational sac on USS

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Not stated

Allocation concealment (selection bias)

Unclear risk

Unclear

Blinding (performance bias and detection bias)
All outcomes

Low risk

No blinding stated, but outcome was not likely to be influenced

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Complete outcome data (pre‐ and after cross‐over)

Selective reporting (reporting bias)

Unclear risk

No protocol available, adverse effects not stated

Other bias

High risk

Cross‐over design

Guzick 1999

Methods

Design: parallel

Power calculation: not stated

ITT: unclear

Number of couples randomised: 932

Number of couples analysed: not stated

Number of couples included in this review: 254

Number of started cycles: 4676

Number of completed cycles: 2678

Number of drop‐outs: 167

Number of cancelled cycles: 292

Centre: multicentre, 10 clinical sites, USA

Participants

Couples: male and unexplained subfertility

Definition male subfertility: sperm concentration < 20 million/mL, motility < 50%

Number of semen samples: not stated

Age of women (whole group): 32 years (SD ± 4)

Duration of subfertility: IUI in natural cycle 34 months (SD ± 4), IUI with OH cycle 35 (SD ± 5)

Primary/secondary subfertility: mixed

Ovulatory status: in phase endometrial biopsy

Tubal patency: DLS + HSG

PCT: not stated

Previous treatment: none

Exclusion criteria: antisperm antibodies

Interventions

Comparison: IUI with OH cycles vs. IUI in natural cycles (ICI in natural cycles vs. ICI with OH cycles)

Treatment duration: maximum 6 cycles

Method OH: FSH 150 IU days 3‐7, from day 8 onwards dose adjusted

Timing ovulation for IUI in natural cycles: LH surge urine

Timing ovulation for IUI + OH cycles: measurement of 2 follicles ≥ 18 mm, serum oestradiol concentration 500‐3000 pg/mL

Ovulation induction (IUI + OH cycles): hCG 10,000 IU

Number of IUI per cycle: 1

Timing IUI in natural cycles: day after LH surge

Timing IUI + OH cycles: 36‐40 hours after hCG

Sperm preparation: Ham's F‐10

Number of inseminated spermatozoa: not stated

Cancellation criteria: if no surge in urinary excretion LH for IUI in natural cycle or for IUI + OH if serum oestradiol after 3 days > 3000 pg/mL

Outcomes

Live birth per couple or cycle, PR per couple or cycle

OHSS rate: stated

Miscarriage rate: stated

Multiple PR: stated

Ectopic PR: stated

Definition/diagnosis pregnancy: hCG measured on day 15 and 17

Notes

Author provided separate data for male subfertility, but states that randomisation might not hold

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Computer‐generated permuted block procedure

Allocation concealment (selection bias)

Low risk

Locked computer files

Blinding (performance bias and detection bias)
All outcomes

Low risk

No blinding stated, but outcome was not likely to be influenced

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Author supplied separate data for male subfertility

Selective reporting (reporting bias)

Unclear risk

No protocol available

Other bias

Low risk

No other bias

Kerin 1984

Methods

Design: cross‐over alternating

Pre‐cross‐over data: partly extractable

Power calculation: not stated

ITT: not stated

Number of couples randomised: 35

Number of couples analysed: 35

Number of couples included in this review: 21

Number of started cycles: not stated

Number of completed cycles: 39

Number of drop‐outs: not stated

Number of cancelled cycles: not stated

Centre: single centre, Adelaide, Australia

Participants

Couples: male subfertility

Definition male subfertility: ≥ 2 of the following criteria: sperm density < 40 million/mL, motility < 45%, normal morphology < 40%, < 60 million motile spermatozoa

Number of semen samples: ≥ 3

Age of women: not stated

Duration of subfertility: > 3 years, not further specified

Primary/secondary subfertility: not stated

Ovulatory status: luteal progesterone > 20 nmol/L

Tubal patency: laparoscopic tubal dye insufflation test

PCT: done

Previous treatment: not stated

Exclusion criteria: positive PCT

Interventions

Comparison: IUI in natural cycles vs. TI in natural cycles vs. natural cycles

Treatment duration: maximum 12 cycles

Timing ovulation natural cycles: symptothermal methods

Timing ovulation TI in natural cycles and IUI in natural cycles: LH surge

Ovulation induction: none

Timing IUI: day of LH surge

Timing intercourse: day after LH surge

Number of inseminations: 1
Sperm preparation: Wittingham's T6 medium wash with swim‐up

Number of inseminated spermatozoa: stated

Cancellation criteria: not stated

Outcomes

PR per completed cycle

OHSS: not stated

Miscarriage rate: not stated

Multiple PR: not stated

Ectopic PR: not stated

Definition/diagnosis pregnancy: not further defined

Notes

Pre‐cross‐over data only partly available. No reply from author, received letter back as wrongly addressed

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Not stated

Allocation concealment (selection bias)

Unclear risk

Unclear

Blinding (performance bias and detection bias)
All outcomes

Low risk

No blinding stated, but outcome was not likely to be influenced

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Pre‐cross‐over data partly available

Selective reporting (reporting bias)

Unclear risk

No protocol available, adverse effects not stated

Other bias

High risk

Cross‐over design

Melis 1995

Methods

Design: parallel

Power calculation: not stated

ITT: no

Number of couples randomised: 200

Number of couples analysed: 184

Number of couples included in this review: 81

Number of started cycles: not stated

Number of completed cycles: 462, 213 for male subfertility

Number of drop‐outs/cancelled cycles: 16; 11 for male subfertility (family problems (n = 5), poor response to ovulation induction (n = 3), exaggerated response to ovulation induction (n = 8)

Centre: single centre, Cagliari, Italy

Participants

Couples: male (n = 92) and unexplained (n = 108) subfertility

Definition male subfertility: sperm concentration 10‐20 million/mL, progressive motility 15‐25%, total motility 30‐50%, normal morphology 30‐50%

Number of semen samples: ≥ 2

Age of women: 34.2 years (SD ± 4.8, range 27‐36)

Duration of subfertility: 51.2 months (SD ± 14.3)

Primary/secondary subfertility: not stated

Ovulatory status: in‐phase endometrial biopsy, USS evidence ovulation, female endocrine profile

Tubal patency: DLS, HSG

PCT: done

Previous treatments: all couples had received 3 cycles CC‐induced TI and 3 cycles CC‐induced IUI

Exclusion criteria: severe male subfertility, female factor subfertility

Interventions

Comparison: IUI with OH cycles vs. TI with OH cycles

Treatment duration: maximum 3 cycles

Method OH: 3 ampoules FSH starting from cycle day 3, personally adjusted to endocrine monitoring and USS

Timing of ovulation induction: measurement of at least 2 follicle ≥ 16 mm and oestradiol 800‐1500 pg/mL

Ovulation induction: 10.000 hCG 36 hours after last injection FSH

Number of IUI per cycle: 1

Timing of IUI: 30‐36 hours after hCG

Timing intercourse: 12 hours after hCG

Sperm preparation: wash (Menezo B2) and swim unconventional layering technique

Number of inseminated spermatozoa: not stated

Cancellation criteria: oestradiol > 1500 pg/mL or poor response to OH

Outcomes

PR per couple PR per completed cycle

OHSS: stated

Miscarriage rate: stated

Multiple PR: stated

Ectopic PR: stated

Definition/diagnosis pregnancy: hCG (> 25 IU/L) in serum always confirmed by USS

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Computer‐generated random numbers table

Allocation concealment (selection bias)

Low risk

Numbered sealed envelopes

Blinding (performance bias and detection bias)
All outcomes

Low risk

No blinding stated, but outcome was not likely to be influenced

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Less than 95% of the couples included in analysis

Selective reporting (reporting bias)

Unclear risk

No protocol available

Other bias

Low risk

No other bias

Nan 1994

Methods

Design: cross‐over alternating

Pre‐cross‐over data: available

Power calculation: not stated

ITT: not stated

Number of couples randomised: 76

Number of couples analysed: 76

Number of couples included in this review: 59

Number of started cycles: 249

Number of completed cycles: 202

Number of drop‐outs: not stated

Number of cancelled cycles: 47

Centre: single centre, University Hospital Utrecht, the Netherlands

Participants

Couples: male subfertility

Definition male subfertility: sperm concentration < 20 million/mL, total motility < 40%, normal morphology < 40%, or a combination of these

Number of semen samples: 4

Age of women: 32 years (range 24‐39)

Duration of subfertility: 4.5 years (range 2‐10)

Primary/secondary subfertility: mixed

Ovulatory status: BBT, luteal progesterone ≥ 31 nmol/L

Tubal patency: DLS, HSG

PCT: done

Previous fertility treatment: not stated

Exclusion criteria: sperm antibodies

Interventions

Comparison: IUI with OH cycles vs. TI with OH cycles

Treatment duration: maximum 6 cycles

Method OH: 150 IU HMG/day starting from cycle day 3

Timing ovulation: measurement of leading follicle ≥ 18 mm and LH surge

Ovulation induction: hCG 10,000 IU

Number of IUI per cycle: 1

Timing IUI: 38‐40 hours after hCG injections or following morning in case LH surged

Timing intercourse: evening next day, or same evening in case LH surged

Method of semen preparation; Wash (Ham's F10) and Percoll gradient technique

Number of inseminated spermatozoa: not stated

Cancellation criteria: ≥ 4 follicles ≥ 18 mm or oestradiol > 6000 pmol/L

Outcomes

Live birth per cycle, PR per completed cycle, PR per started cycle

OHSS: stated

Miscarriage rate: stated

Multiple PR: stated

Ectopic PR: not stated

Abruptio placenta: stated

Definition/diagnosis pregnancy: HCG urine and USS confirmation

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Random number table

Allocation concealment (selection bias)

Low risk

Numbered sealed opaque envelopes

Blinding (performance bias and detection bias)
All outcomes

Low risk

No blinding stated, but outcome was not likely to be influenced

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Complete outcome data

Selective reporting (reporting bias)

Unclear risk

No protocol available

Other bias

High risk

Cross‐over design

ART: assisted reproductive technique; BBT: basal body temperature; CC: clomiphene citrate; COH: controlled ovarian hyperstimulation; DLS: diagnostic laparoscopic surgery; FSH: follicle‐stimulating hormone; GnRH: gonadotropin‐releasing hormone; hCG: human chorionic gonadotrophin; hMG: human menopausal gonadotrophin; HSG: hysterosalpingography; ICI: intra‐cervical insemination; IQR: interquartile range; IM: intramuscular; ITT: intention to treat; IU: international unit; IUI: intra‐uterine insemination; IVF: in vitro fertilisation; LH: luteinising hormone; MNC: modified natural cycle; n: number of couples; OAT: oligoasthenoteratozoospermia; OH: ovarian hyperstimulation; OHSS: ovarian hyperstimulation syndrome; PCT: post coital test; PR: pregnancy rate; SD: standard deviation; SET: single embryo transfer; TI: timed intercourse; TMSC: total motile sperm count; USS: ultrasound scan.

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Aboulghar 1995

Oocytes were randomly divided between IVF and ICSI, no outcome data available per couple

Aboulghar 1996

Oocytes were randomly divided between IVF and ICSI, no outcome data available per couple

Agarwal 2004

Unexplained subfertility couples

Buvat 1990

Number of couples receiving IUI and TI was not stated

Crosignani 1994

Authors could not provide pre‐cross‐over data

Cruz 1986

Different comparison: IUI vs. ICI

Elizur 2004

Not an RCT, but a retrospective study

Elzeiny 2014

Unexplained subfertility couples

Evans 1991

Biochemical pregnancies only, no response from the author

Fan 2012

Oocytes were randomised between IVF and ICSI, no outcome data available per couple

Fishel 2000

Oocytes were randomised between IVF and ICSI, no outcome data available per couple

Friedman 1989

Preliminary report, different comparison: IUI vs. ICI

Galle 1990

Not an RCT, but an observational study

Goverde 2001

Not an RCT, correspondence

Hewitt 1985

Not an RCT, an observational study

Ho 1989

Authors could not provide pre‐cross‐over data

Ho 1992

Authors could not provide pre‐cross‐over data

Karlström 2000

Compares IUI both with different forms of OH

Kastrop 1999

Oocytes were randomly divided between IVF and ICSI, no outcome data available per couple

Kihaile 2003

Oocytes were randomly divided between IVF and ICSI, no outcome data available per couple

Kirby 1991

Authors could not provide pre‐cross‐over data

Li 2004

Oocytes were randomly divided between IVF and ICSI, no outcome data available per couple

Martinez 1991

Authors could not provide pre‐cross‐over data

Melis 1987

Different comparison: ICI in natural cycle vs. ICI with OH

Moolenaar 2015

Not an RCT, but a retrospective study

Nulsen 1993

Not an RCT: quasi randomised, biochemical pregnancies only

Pisarska 1999

Oocytes were randomly divided between IVF and ICSI, no outcome data available per couple

Plachot 2002

Not an RCT: oocytes were quasi randomised between IVF and ICSI

Prentice 1995

Not an RCT: quasi randomised, based on hospital case record number

Soliman 1993

Incomplete data on treatment of control group

te Velde 1989

Authors could not provide pre‐cross‐over data

Tournaye 2002

Oocytes were randomly divided between IVF and ICSI, no outcome data available per couple

van der Westerlaken 2006

Oocytes were randomly divided between IVF and ICSI, no outcome data available per couple

Verheyen 1999

Oocytes were randomly divided between IVF and ICSI, no outcome data available per couple

Xie 2015

Not an RCT

Zayed 1997

Not an RCT: quasi randomised, patient preference

ICI: intra‐cervical insemination; ICSI: intracytoplasmic sperm injection; IUI: intra‐uterine insemination; IVF: in vitro fertilisation; OH: ovarian hyperstimulation; RCT: randomised controlled trial; TI: timed intercourse.

Characteristics of studies awaiting assessment [ordered by study ID]

Aribarg 1995

Methods

Design: cross‐over alternating

Pre‐cross‐over data: not stated

Power calculation: not stated

ITT: not done, could not be extracted

Number of couples randomised: not stated

Number of couples analysed: 50

Number of started cycles: not stated

Number of completed cycles: 495

Number of drop‐outs: not stated

Number of cancelled cycles: not stated

Centre: single centre, Chulalongkorn University, Bangkok, Thailand

Participants

Couples: male subfertility

Definition male subfertility: sperm concentration 1‐20 million/mL, motility < 50%, normal morphology < 30%, or a combination of these (WHO 1992)

Number of semen samples: 2

Age of women: mean 25.5 years (range 23‐37)

Duration of subfertility: mean 3.7 years (range 2‐15)

Primary/secondary subfertility: not stated

Ovulatory status: BBT

Tubal patency: DLS and HSG

PCT: not stated

Previous treatments: not stated

Exclusion criteria: severe oligospermia < 1 million/mL, semen with evidence of bacterial infection, women with endometriosis, hormonal, tubal or ovulatory disturbance diagnosed

Interventions

Comparison: IUI with OH cycles vs. TI in natural cycles

Treatment duration: maximum 4‐6 cycles

Method of OH: CC 100 mg/day (cycle day 3‐7)

Ovulation induction: none

Number of IUI per cycle: 1, sometimes 2

Timing of IUI: timed by USS, BBT and LH surge urine

Timing of intercourse: evening of the day of the LH surge and on the following day

Sperm preparation: wash and swim up, Ham's F‐10 medium

Number of inseminated spermatozoa: no conception observed below threshold of < 5 million motile spermatozoa

Cancellation criteria: not stated

Outcomes

PR per completed cycle

OHSS: not stated

Miscarriage rate: stated

Multiple PR: stated

Ectopic PR: not stated

Definition/diagnosis pregnancy: hCG in blood and confirmation by USS, clinical examination

Notes

Quality of spermatozoa in terms of their concentration and motility before and after sperm washing was compared

No pre‐cross‐over data available, no reply from author

Jaroudi 1998

Methods

Design: cross‐over alternating

Pre‐cross‐data: not stated

Power calculation: not stated

ITT: not stated

Number of couples randomised: 36

Number of couples analysed: 36

Number of started cycles: not stated

Number of completed cycles: 110

Number of drop‐outs: not stated

Number of cancelled cycles: not stated

Centre: single centre, Riyadh, Saudi Arabia

Participants

Couples: male subfertility

Definition male subfertility: sperm count 1‐20 million/mL or motility 10‐30% with > 1 million total spermatozoa

Number of semen samples: 3

Age of women: 27 years (SD ± 3.7)

Duration of subfertility: 6.5 years (SD ± 3.0)

Primary/secondary subfertility: not stated

Ovulatory status: not stated

Tubal patency: HSG

PCT: not stated

Previous treatment: not stated

Exclusion criteria: not stated

Interventions

Comparison: IUI with OH cycles vs. TI with OH cycles

Treatment duration: maximum 6 cycles

Method OH: hMG 150 IU/day started from cycle day 3 (adjusting to woman's response), buserelin acetate spray 500 μg/day started from cycle day 2

Timing of ovulation: measurement of 3‐5 follicles > 15 mm and appropriate plasma oestradiol concentration (800 pmol/L per follicle)

Ovulation induction: hCG 10,000 IU

Number of IUI per cycle: 1

Timing of IUI: 34 hours after hCG

Timing of intercourse: 36 hours after hCG

Luteal support: progesterone 200 mg/day

Sperm preparation: Percoll gradient technique

Number of inseminated spermatozoa: not stated

Cancellation criteria: not stated

Outcomes

PR per completed cycle

OHSS: not stated

Miscarriage rate: not stated

Multiple PR: not stated

Ectopic PR: not stated

Definition/diagnosis pregnancy: USS 6‐7 weeks' gestational sac

Notes

No pre‐cross‐over data available, no reply from author

Kerin 1987

Methods

Design: cross‐over alternating

Pre‐cross‐over data: not stated

Power calculation: not stated

ITT: not stated

Number of couples randomised: not stated

Number of couples analysed: not stated

Number of started cycles: not stated

Number of completed cycles: 509

Number of drop‐outs: not stated

Number of cancelled cycles: not stated

Centre: single centre, Los Angeles, USA

Participants

Couples: male subfertility

Definition male subfertility: assessment of at least 2 abnormalities:

  • moderate: sperm concentration 10‐40 million/mL, sperm motility 30‐40%, sperm morphology 30‐40%, or a combination of these

  • severe: sperm density < 10 million/mL, motility < 30%, morphology < 30%, or a combination of these

Number of semen samples: 3

Age of women: < 41 years, not specified

Duration of subfertility: ≥ 3 years, not specified

Primary/secondary subfertility: primary

Ovulatory status: normal endocrine profile (LH, FSH, prolactin)

Tubal patency: tested, not further specified

PCT: not stated

Previous treatment: not stated

Exclusion criteria: sperm antibodies, endometriosis, sperm count < 100,000 after preparation

Interventions

Comparison: IUI in natural cycles vs. TI in natural cycles

Treatment duration: maximum 12 cycles

Timing of ovulation: LH surge urine

Ovulation induction: none

Number of IUI per cycle: 1

Timing of IUI: first of second day after LH surge

Timing of intercourse: day of LH surge

Sperm preparation: swim up procedure

Number of inseminated spermatozoa: stated

Cancellation criteria: not stated

Outcomes

PR per completed cycle

OHSS: not stated

Miscarriage rate: stated

Multiple PR: not stated

Ectopic PR: stated

Definition/diagnosis pregnancy: not stated

Notes

Stratified for moderate semen defect and severe semen defect

Compared IUI within 24 hours and within 48 hours after LH surge

No pre‐cross‐over data available, no reply from author

BBT: basal body temperature; CC: clomiphene citrate; DLS: diagnostic laparoscopic surgery; FSH: follicle‐stimulating hormone; hCG: human chorionic gonadotrophin, hMG: human menopausal gonadotrophin; HSG: hysterosalpingography; ITT: intention to treat; IUI: intra‐uterine insemination; LH: luteinising hormone; OH: ovarian hyperstimulation; OHSS: ovarian hyperstimulation syndrome; PCT= post coital test, PR: pregnancy rate; SD: standard deviation; TI: timed intercourse; USS: ultrasound scan.

Data and analyses

Open in table viewer
Comparison 1. Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in natural cycles (NC)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Pregnancy rate per couple (all cycles) Show forest plot

2

62

Odds Ratio (M‐H, Fixed, 95% CI)

4.57 [0.21, 101.61]

Analysis 1.1

Comparison 1 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in natural cycles (NC), Outcome 1 Pregnancy rate per couple (all cycles).

Comparison 1 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in natural cycles (NC), Outcome 1 Pregnancy rate per couple (all cycles).

Open in table viewer
Comparison 2. Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in cycles with ovarian hyperstimulation (OH)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Live birth rate per couple (all cycles) Show forest plot

1

81

Odds Ratio (M‐H, Fixed, 95% CI)

0.89 [0.30, 2.59]

Analysis 2.1

Comparison 2 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in cycles with ovarian hyperstimulation (OH), Outcome 1 Live birth rate per couple (all cycles).

Comparison 2 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in cycles with ovarian hyperstimulation (OH), Outcome 1 Live birth rate per couple (all cycles).

2 OHSS per couple Show forest plot

1

59

Odds Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

Analysis 2.2

Comparison 2 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in cycles with ovarian hyperstimulation (OH), Outcome 2 OHSS per couple.

Comparison 2 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in cycles with ovarian hyperstimulation (OH), Outcome 2 OHSS per couple.

3 Pregnancy rate per couple (all cycles) Show forest plot

3

202

Odds Ratio (M‐H, Fixed, 95% CI)

1.51 [0.74, 3.07]

Analysis 2.3

Comparison 2 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in cycles with ovarian hyperstimulation (OH), Outcome 3 Pregnancy rate per couple (all cycles).

Comparison 2 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in cycles with ovarian hyperstimulation (OH), Outcome 3 Pregnancy rate per couple (all cycles).

4 Multiple pregnancy rate per couple Show forest plot

1

81

Odds Ratio (M‐H, Fixed, 95% CI)

3.15 [0.12, 79.69]

Analysis 2.4

Comparison 2 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in cycles with ovarian hyperstimulation (OH), Outcome 4 Multiple pregnancy rate per couple.

Comparison 2 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in cycles with ovarian hyperstimulation (OH), Outcome 4 Multiple pregnancy rate per couple.

5 Miscarriage rate per couple Show forest plot

1

81

Odds Ratio (M‐H, Fixed, 95% CI)

1.03 [0.19, 5.42]

Analysis 2.5

Comparison 2 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in cycles with ovarian hyperstimulation (OH), Outcome 5 Miscarriage rate per couple.

Comparison 2 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in cycles with ovarian hyperstimulation (OH), Outcome 5 Miscarriage rate per couple.

Open in table viewer
Comparison 4. Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus timed intercourse (TI) in natural cycles (NC)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Live birth rate per couple (all cycles) Show forest plot

1

44

Odds Ratio (M‐H, Fixed, 95% CI)

3.14 [0.12, 81.35]

Analysis 4.1

Comparison 4 Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus timed intercourse (TI) in natural cycles (NC), Outcome 1 Live birth rate per couple (all cycles).

Comparison 4 Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus timed intercourse (TI) in natural cycles (NC), Outcome 1 Live birth rate per couple (all cycles).

2 Pregnancy rate per couple (all cycles) Show forest plot

1

44

Odds Ratio (M‐H, Fixed, 95% CI)

3.14 [0.12, 81.35]

Analysis 4.2

Comparison 4 Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus timed intercourse (TI) in natural cycles (NC), Outcome 2 Pregnancy rate per couple (all cycles).

Comparison 4 Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus timed intercourse (TI) in natural cycles (NC), Outcome 2 Pregnancy rate per couple (all cycles).

Open in table viewer
Comparison 5. Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus IUI in natural cycles (NC)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Live birth rate per couple (all cycles) Show forest plot

3

346

Odds Ratio (M‐H, Fixed, 95% CI)

1.34 [0.77, 2.33]

Analysis 5.1

Comparison 5 Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus IUI in natural cycles (NC), Outcome 1 Live birth rate per couple (all cycles).

Comparison 5 Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus IUI in natural cycles (NC), Outcome 1 Live birth rate per couple (all cycles).

1.1 Gonadotrophins

2

305

Odds Ratio (M‐H, Fixed, 95% CI)

1.31 [0.75, 2.29]

1.2 Gonadotrophins + clomiphene citrate (CC)

1

41

Odds Ratio (M‐H, Fixed, 95% CI)

2.72 [0.10, 70.79]

2 Pregnancy rate per couple (all cycles) Show forest plot

4

399

Odds Ratio (M‐H, Fixed, 95% CI)

1.68 [1.00, 2.82]

Analysis 5.2

Comparison 5 Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus IUI in natural cycles (NC), Outcome 2 Pregnancy rate per couple (all cycles).

Comparison 5 Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus IUI in natural cycles (NC), Outcome 2 Pregnancy rate per couple (all cycles).

2.1 Gonadotrophins

2

328

Odds Ratio (M‐H, Fixed, 95% CI)

1.60 [0.94, 2.73]

2.2 CC

1

30

Odds Ratio (M‐H, Fixed, 95% CI)

4.83 [0.18, 128.79]

2.3 Gonadotrophins + CC

1

41

Odds Ratio (M‐H, Fixed, 95% CI)

2.72 [0.10, 70.79]

3 Miscarriage rate per couple Show forest plot

2

115

Odds Ratio (M‐H, Fixed, 95% CI)

1.06 [0.20, 5.63]

Analysis 5.3

Comparison 5 Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus IUI in natural cycles (NC), Outcome 3 Miscarriage rate per couple.

Comparison 5 Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus IUI in natural cycles (NC), Outcome 3 Miscarriage rate per couple.

Open in table viewer
Comparison 8. In vitro fertilisation (IVF) versus intra‐uterine insemination (IUI) in natural cycles (NC)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Live birth rate per couple (all cycles) Show forest plot

1

53

Odds Ratio (M‐H, Fixed, 95% CI)

0.77 [0.25, 2.35]

Analysis 8.1

Comparison 8 In vitro fertilisation (IVF) versus intra‐uterine insemination (IUI) in natural cycles (NC), Outcome 1 Live birth rate per couple (all cycles).

Comparison 8 In vitro fertilisation (IVF) versus intra‐uterine insemination (IUI) in natural cycles (NC), Outcome 1 Live birth rate per couple (all cycles).

Open in table viewer
Comparison 9. In vitro fertilisation (IVF) versus intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Live birth rate per couple (all cycles) Show forest plot

2

86

Odds Ratio (M‐H, Fixed, 95% CI)

1.03 [0.43, 2.45]

Analysis 9.1

Comparison 9 In vitro fertilisation (IVF) versus intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH), Outcome 1 Live birth rate per couple (all cycles).

Comparison 9 In vitro fertilisation (IVF) versus intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH), Outcome 1 Live birth rate per couple (all cycles).

2 OHSS per couple Show forest plot

1

36

Odds Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

Analysis 9.2

Comparison 9 In vitro fertilisation (IVF) versus intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH), Outcome 2 OHSS per couple.

Comparison 9 In vitro fertilisation (IVF) versus intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH), Outcome 2 OHSS per couple.

3 Pregnancy rate per couple (all cycles) Show forest plot

1

36

Odds Ratio (M‐H, Fixed, 95% CI)

1.27 [0.33, 4.97]

Analysis 9.3

Comparison 9 In vitro fertilisation (IVF) versus intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH), Outcome 3 Pregnancy rate per couple (all cycles).

Comparison 9 In vitro fertilisation (IVF) versus intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH), Outcome 3 Pregnancy rate per couple (all cycles).

Study flow diagram.
Figuras y tablas -
Figure 1

Study flow diagram.

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
Figuras y tablas -
Figure 2

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
Figuras y tablas -
Figure 3

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Forest plot of comparison: 1 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in natural cycles (NC), outcome: 1.1 Pregnancy rate per couple (all cycles).
Figuras y tablas -
Figure 4

Forest plot of comparison: 1 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in natural cycles (NC), outcome: 1.1 Pregnancy rate per couple (all cycles).

Forest plot of comparison: 2 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in cycles with ovarian hyperstimulation (OH), outcome: 2.3 Pregnancy rate per couple (all cycles).
Figuras y tablas -
Figure 5

Forest plot of comparison: 2 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in cycles with ovarian hyperstimulation (OH), outcome: 2.3 Pregnancy rate per couple (all cycles).

Forest plot of comparison: 4 Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus timed intercourse (TI) in natural cycles (NC), outcome: 4.2 Pregnancy rate per couple (all cycles).
Figuras y tablas -
Figure 6

Forest plot of comparison: 4 Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus timed intercourse (TI) in natural cycles (NC), outcome: 4.2 Pregnancy rate per couple (all cycles).

Forest plot of comparison: 5 Intra‐uterine insemination (IUI) in natural cycles (NC) versus IUI in cycles with ovarian hyperstimulation (OH) versus IUI in natural cycles (NC), outcome: 5.2 Pregnancy rate per couple (all cycles).
Figuras y tablas -
Figure 7

Forest plot of comparison: 5 Intra‐uterine insemination (IUI) in natural cycles (NC) versus IUI in cycles with ovarian hyperstimulation (OH) versus IUI in natural cycles (NC), outcome: 5.2 Pregnancy rate per couple (all cycles).

Forest plot of comparison: 8 In vitro fertilisation (IVF) versus intra‐uterine insemination (IUI) in natural cycles (NC), outcome: 8.1 Live birth rate per couple (all cycles).
Figuras y tablas -
Figure 8

Forest plot of comparison: 8 In vitro fertilisation (IVF) versus intra‐uterine insemination (IUI) in natural cycles (NC), outcome: 8.1 Live birth rate per couple (all cycles).

Forest plot of comparison: 9 In vitro fertilisation (IVF) versus intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH), outcome: 9.1 Live birth rate per couple (all cycles).
Figuras y tablas -
Figure 9

Forest plot of comparison: 9 In vitro fertilisation (IVF) versus intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH), outcome: 9.1 Live birth rate per couple (all cycles).

Comparison 1 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in natural cycles (NC), Outcome 1 Pregnancy rate per couple (all cycles).
Figuras y tablas -
Analysis 1.1

Comparison 1 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in natural cycles (NC), Outcome 1 Pregnancy rate per couple (all cycles).

Comparison 2 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in cycles with ovarian hyperstimulation (OH), Outcome 1 Live birth rate per couple (all cycles).
Figuras y tablas -
Analysis 2.1

Comparison 2 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in cycles with ovarian hyperstimulation (OH), Outcome 1 Live birth rate per couple (all cycles).

Comparison 2 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in cycles with ovarian hyperstimulation (OH), Outcome 2 OHSS per couple.
Figuras y tablas -
Analysis 2.2

Comparison 2 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in cycles with ovarian hyperstimulation (OH), Outcome 2 OHSS per couple.

Comparison 2 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in cycles with ovarian hyperstimulation (OH), Outcome 3 Pregnancy rate per couple (all cycles).
Figuras y tablas -
Analysis 2.3

Comparison 2 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in cycles with ovarian hyperstimulation (OH), Outcome 3 Pregnancy rate per couple (all cycles).

Comparison 2 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in cycles with ovarian hyperstimulation (OH), Outcome 4 Multiple pregnancy rate per couple.
Figuras y tablas -
Analysis 2.4

Comparison 2 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in cycles with ovarian hyperstimulation (OH), Outcome 4 Multiple pregnancy rate per couple.

Comparison 2 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in cycles with ovarian hyperstimulation (OH), Outcome 5 Miscarriage rate per couple.
Figuras y tablas -
Analysis 2.5

Comparison 2 Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in cycles with ovarian hyperstimulation (OH), Outcome 5 Miscarriage rate per couple.

Comparison 4 Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus timed intercourse (TI) in natural cycles (NC), Outcome 1 Live birth rate per couple (all cycles).
Figuras y tablas -
Analysis 4.1

Comparison 4 Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus timed intercourse (TI) in natural cycles (NC), Outcome 1 Live birth rate per couple (all cycles).

Comparison 4 Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus timed intercourse (TI) in natural cycles (NC), Outcome 2 Pregnancy rate per couple (all cycles).
Figuras y tablas -
Analysis 4.2

Comparison 4 Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus timed intercourse (TI) in natural cycles (NC), Outcome 2 Pregnancy rate per couple (all cycles).

Comparison 5 Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus IUI in natural cycles (NC), Outcome 1 Live birth rate per couple (all cycles).
Figuras y tablas -
Analysis 5.1

Comparison 5 Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus IUI in natural cycles (NC), Outcome 1 Live birth rate per couple (all cycles).

Comparison 5 Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus IUI in natural cycles (NC), Outcome 2 Pregnancy rate per couple (all cycles).
Figuras y tablas -
Analysis 5.2

Comparison 5 Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus IUI in natural cycles (NC), Outcome 2 Pregnancy rate per couple (all cycles).

Comparison 5 Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus IUI in natural cycles (NC), Outcome 3 Miscarriage rate per couple.
Figuras y tablas -
Analysis 5.3

Comparison 5 Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus IUI in natural cycles (NC), Outcome 3 Miscarriage rate per couple.

Comparison 8 In vitro fertilisation (IVF) versus intra‐uterine insemination (IUI) in natural cycles (NC), Outcome 1 Live birth rate per couple (all cycles).
Figuras y tablas -
Analysis 8.1

Comparison 8 In vitro fertilisation (IVF) versus intra‐uterine insemination (IUI) in natural cycles (NC), Outcome 1 Live birth rate per couple (all cycles).

Comparison 9 In vitro fertilisation (IVF) versus intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH), Outcome 1 Live birth rate per couple (all cycles).
Figuras y tablas -
Analysis 9.1

Comparison 9 In vitro fertilisation (IVF) versus intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH), Outcome 1 Live birth rate per couple (all cycles).

Comparison 9 In vitro fertilisation (IVF) versus intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH), Outcome 2 OHSS per couple.
Figuras y tablas -
Analysis 9.2

Comparison 9 In vitro fertilisation (IVF) versus intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH), Outcome 2 OHSS per couple.

Comparison 9 In vitro fertilisation (IVF) versus intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH), Outcome 3 Pregnancy rate per couple (all cycles).
Figuras y tablas -
Analysis 9.3

Comparison 9 In vitro fertilisation (IVF) versus intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH), Outcome 3 Pregnancy rate per couple (all cycles).

Summary of findings for the main comparison. IUI in natural cycles compared to TI in natural cycles for male subfertility

IUI in natural cycles compared to TI in natural cycles for male subfertility

Patient or population: couples with male subfertility
Settings: single centre (Australia, Italy)
Intervention: IUI in natural cycles
Comparison: TI in natural cycles

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of couples (studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

TI in natural cycles

IUI in natural cycles

Live birth rate

Not reported in any included studies

OHSS

Not reported in any included studies

Pregnancy rate per couple (all cycles)
Follow‐up: 9‐12 months

0 per 1000

0 per 1000
(0 to 0)

OR 4.57
(0.21 to 101.61)

62
(2 studies)

⊕⊝⊝⊝
very low1,2

*The basis for the assumed risk was the median control group risk across studies. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; IUI: intra‐uterine insemination; OHSS: ovarian hyperstimulation syndrome; OR: odds ratio; TI: timed intercourse.

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Risk of bias was very serious: 1. Francavilla 2009, allocation concealment: high risk (on chronological basis), 2. Francavilla 2009, other bias: high risk (no stratification by diagnosis category of subfertility).
2 There was very serious imprecision, with small sample sizes and very few events.

Figuras y tablas -
Summary of findings for the main comparison. IUI in natural cycles compared to TI in natural cycles for male subfertility
Summary of findings 2. IUI in stimulated cycles compared to TI in stimulated cycles for male subfertility

IUI in stimulated cycles compared to TI in stimulated cycles for male subfertility

Patient or population: couples with male subfertility
Settings: single centre (Greece, Italy, The Netherlands)
Intervention: IUI in stimulated cycles
Comparison: TI in stimulated cycles

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of couples (studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

TI in stimulated cycles

IUI in stimulated cycles

Live birth rate per couple (all cycles)
Follow‐up: 3 months

220 per 1000

200 per 1000
(78 to 421)

OR 0.89
(0.30 to 2.59)

81
(1 study)

⊕⊕⊝⊝
low1

OHSS per couple

Follow‐up: 6 months

See comment

See comment

Not estimable

59

(1 study)

⊕⊕⊝⊝
low1

Pregnancy rate per couple (all cycles)
Follow‐up: 3‐6 months

175 per 1000

243 per 1000
(136 to 395)

OR 1.51
(0.74 to 3.07)

202
(3 studies)

⊕⊝⊝⊝
very low1,2

Multiple pregnancy rate per couple
Follow‐up: 3 months

0 per 1000

0 per 1000
(0 to 0)

OR 3.15
(0.12 to 79.69)

81
(1 study)

⊕⊕⊝⊝
low3

Miscarriage rate per couple
Follow‐up: 3 months

73 per 1000

75 per 1000
(15 to 300)

OR 1.03
(0.19 to 5.42)

81
(1 study)

⊕⊕⊝⊝
low3

*The basis for the assumed risk was the median control group risk across studies. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; IUI: intra‐uterine insemination; OHSS: ovarian hyperstimulation syndrome; OR: odds ratio; TI: timed intercourse.

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 There was very serious imprecision, with small sample size.
2 Inconsistency was serious between Melis 1995 (favoured TI + OH) and Gregoriou 1996 and Nan 1994 (favoured IUI + OH).
3 There was very serious imprecision, with small sample sizes and findings were compatible with substantial benefit in either group.

Figuras y tablas -
Summary of findings 2. IUI in stimulated cycles compared to TI in stimulated cycles for male subfertility
Summary of findings 3. IUI in stimulated cycles compared to TI in natural cycles for male subfertility

IUI in stimulated cycles compared to TI in natural cycles for male subfertility

Patient or population: couples with male subfertility
Settings: single centre (Italy)
Intervention: IUI in stimulated cycles
Comparison: TI in natural cycles

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of couples (studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

TI in natural cycles

IUI in stimulated cycles

Live birth rate per couple (all cycles)
Follow‐up: 9 months

0 per 1000

0 per 1000
(0 to 0)

OR 3.14
(0.12 to 81.35)

44
(1 study)

⊕⊝⊝⊝
very low1,2

OHSS

Not reported in any included studies

Pregnancy rate per couple (all cycles)
Follow‐up: 9 months

0 per 1000

0 per 1000
(0 to 0)

OR 3.14
(0.12 to 81.35)

44
(1 study)

⊕⊝⊝⊝
very low1,2

*The basis for the assumed risk was the median control group risk across studies. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; IUI: intra‐uterine insemination; OHSS: ovarian hyperstimulation syndrome; OR: odds ratio; TI: timed intercourse.

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Risk of bias was very serious: 1. Allocation concealment: high risk (on chronological basis), 2. Other bias: high risk (no stratification by diagnosis category of subfertility).
2 There was very serious imprecision, with small sample sizes and very few events.

Figuras y tablas -
Summary of findings 3. IUI in stimulated cycles compared to TI in natural cycles for male subfertility
Summary of findings 4. IUI in stimulated cycles compared to IUI in natural cycles for male subfertility

IUI in stimulated cycles compared to IUI in natural cycles for male subfertility

Patient or population: couples with male subfertility
Settings: single and multicentre (Italy, the Netherlands, USA)
Intervention: IUI in stimulated cycles
Comparison: IUI in natural cycles

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of couples
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

IUI in natural cycles

IUI in stimulated cycles

Live birth rate per couple (all cycles)
Follow‐up: 6‐9 months

172 per 1000

218 per 1000
(138 to 326)

OR 1.34
(0.77 to 2.33)

346
(3 studies)

⊕⊝⊝⊝
very low1,2,3

OHSS

Not reported in any included studies

Pregnancy rate per couple (all cycles)
Follow‐up: 4‐9 months

148 per 1000

226 per 1000
(148 to 329)

OR 1.68
(1.00 to 2.82)

399
(4 studies)

⊕⊝⊝⊝
very low1,3,4

Miscarriage rate per couple
Follow‐up: 6‐9 months

53 per 1000

56 per 1000
(11 to 238)

OR 1.06
(0.20 to 5.63)

115
(2 studies)

⊕⊝⊝⊝
very low5,6

*The basis for the assumed risk was the median control group risk across studies. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; IUI: intra‐uterine insemination; OHSS: ovarian hyperstimulation syndrome; OR: odds ratio.

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Risk of bias was very serious: 1. Francavilla 2009, allocation concealment: high risk (on chronological basis), 2. Arici 1994, Francavilla 2009, and Guzick 1999, other bias: high risk (no stratification by diagnosis category of subfertility.
2 Inconsistency was serious between Cohlen 1998a and Goverde 2000 (favoured IUI in natural cycles) and Arici 1994, Francavilla 2009, and Guzick 1999 (favoured IUI in stimulated cycles).
3 There was serious imprecision, with small sample sizes.
4 Inconsistency was serious between Cohlen 1998a (favoured IUI in natural cycles) and Arici 1994, Francavilla 2009, and Guzick 1999 (favoured IUI in stimulated cycles).
5 Risk of bias was very serious: Francavilla 2009, allocation concealment: high risk (on chronological basis) and other bias: high risk (no stratification by diagnosis category of subfertility).
6 There was serious imprecision, findings were compatible with no benefit in either group.

Figuras y tablas -
Summary of findings 4. IUI in stimulated cycles compared to IUI in natural cycles for male subfertility
Summary of findings 5. IVF compared to IUI in natural cycles for male subfertility

IVF compared to IUI in natural cycles for male subfertility

Patient or population: couples with male subfertility
Settings: single centre (the Netherlands)
Intervention: IVF
Comparison: IUI in natural cycles

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of couples (studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

IUI in natural cycles

IVF

Live birth rate per couple (all cycles)
Follow‐up: 6 months

407 per 1000

346 per 1000
(147 to 618)

OR 0.77
(0.25 to 2.35)

53
(1 study)

⊕⊕⊝⊝
low1

OHSS

Not reported in any included studies

*The basis for the assumed risk was the median control group risk across studies. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; IUI: intra‐uterine insemination; IVF: in vitro fertilisation; OHSS: ovarian hyperstimulation syndrome; OR: odds ratio.

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 There was very serious imprecision, with small sample sizes.

Figuras y tablas -
Summary of findings 5. IVF compared to IUI in natural cycles for male subfertility
Summary of findings 6. IVF compared to IUI in stimulated cycles for male subfertility

IVF compared to IUI in stimulated cycles for male subfertility

Patient or population: couples with male subfertility
Settings: single and multicentre (the Netherlands)
Intervention: IVF
Comparison: IUI in stimulated cycles

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of couples (studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

IUI in stimulated cycles

IVF

Live birth rate per couple (all cycles)
Follow‐up: 6‐12 months

452 per 1000

460 per 1000
(262 to 669)

OR 1.03
(0.43 to 2.45)

86
(2 studies)

⊕⊝⊝⊝
very low1,2

OHSS per couple
Follow‐up: 6 months

See comment

See comment

Not estimable

36
(1 study)

⊕⊝⊝⊝
very low1,2

No OHSS occurred

Pregnancy rate per couple (all cycles)
Follow‐up: 6 months

611 per 1000

666 per 1000
(341 to 886)

OR 1.27
(0.33 to 4.97)

36
(1 study)

⊕⊝⊝⊝
very low1,2

*The basis for the assumed risk was the median control group risk across studies. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; IUI: intra‐uterine insemination; IVF: in vitro fertilisation; OHSS: ovarian hyperstimulation syndrome; OR: odds ratio.

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Risk of bias was serious: Bensdorp 2015, other bias: high risk (no stratification by diagnosis category of subfertility).
2 There was very serious imprecision, with small sample sizes.

Figuras y tablas -
Summary of findings 6. IVF compared to IUI in stimulated cycles for male subfertility
Comparison 1. Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in natural cycles (NC)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Pregnancy rate per couple (all cycles) Show forest plot

2

62

Odds Ratio (M‐H, Fixed, 95% CI)

4.57 [0.21, 101.61]

Figuras y tablas -
Comparison 1. Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in natural cycles (NC)
Comparison 2. Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in cycles with ovarian hyperstimulation (OH)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Live birth rate per couple (all cycles) Show forest plot

1

81

Odds Ratio (M‐H, Fixed, 95% CI)

0.89 [0.30, 2.59]

2 OHSS per couple Show forest plot

1

59

Odds Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

3 Pregnancy rate per couple (all cycles) Show forest plot

3

202

Odds Ratio (M‐H, Fixed, 95% CI)

1.51 [0.74, 3.07]

4 Multiple pregnancy rate per couple Show forest plot

1

81

Odds Ratio (M‐H, Fixed, 95% CI)

3.15 [0.12, 79.69]

5 Miscarriage rate per couple Show forest plot

1

81

Odds Ratio (M‐H, Fixed, 95% CI)

1.03 [0.19, 5.42]

Figuras y tablas -
Comparison 2. Intra‐uterine insemination (IUI) versus timed intercourse (TI) both in cycles with ovarian hyperstimulation (OH)
Comparison 4. Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus timed intercourse (TI) in natural cycles (NC)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Live birth rate per couple (all cycles) Show forest plot

1

44

Odds Ratio (M‐H, Fixed, 95% CI)

3.14 [0.12, 81.35]

2 Pregnancy rate per couple (all cycles) Show forest plot

1

44

Odds Ratio (M‐H, Fixed, 95% CI)

3.14 [0.12, 81.35]

Figuras y tablas -
Comparison 4. Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus timed intercourse (TI) in natural cycles (NC)
Comparison 5. Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus IUI in natural cycles (NC)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Live birth rate per couple (all cycles) Show forest plot

3

346

Odds Ratio (M‐H, Fixed, 95% CI)

1.34 [0.77, 2.33]

1.1 Gonadotrophins

2

305

Odds Ratio (M‐H, Fixed, 95% CI)

1.31 [0.75, 2.29]

1.2 Gonadotrophins + clomiphene citrate (CC)

1

41

Odds Ratio (M‐H, Fixed, 95% CI)

2.72 [0.10, 70.79]

2 Pregnancy rate per couple (all cycles) Show forest plot

4

399

Odds Ratio (M‐H, Fixed, 95% CI)

1.68 [1.00, 2.82]

2.1 Gonadotrophins

2

328

Odds Ratio (M‐H, Fixed, 95% CI)

1.60 [0.94, 2.73]

2.2 CC

1

30

Odds Ratio (M‐H, Fixed, 95% CI)

4.83 [0.18, 128.79]

2.3 Gonadotrophins + CC

1

41

Odds Ratio (M‐H, Fixed, 95% CI)

2.72 [0.10, 70.79]

3 Miscarriage rate per couple Show forest plot

2

115

Odds Ratio (M‐H, Fixed, 95% CI)

1.06 [0.20, 5.63]

Figuras y tablas -
Comparison 5. Intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH) versus IUI in natural cycles (NC)
Comparison 8. In vitro fertilisation (IVF) versus intra‐uterine insemination (IUI) in natural cycles (NC)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Live birth rate per couple (all cycles) Show forest plot

1

53

Odds Ratio (M‐H, Fixed, 95% CI)

0.77 [0.25, 2.35]

Figuras y tablas -
Comparison 8. In vitro fertilisation (IVF) versus intra‐uterine insemination (IUI) in natural cycles (NC)
Comparison 9. In vitro fertilisation (IVF) versus intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Live birth rate per couple (all cycles) Show forest plot

2

86

Odds Ratio (M‐H, Fixed, 95% CI)

1.03 [0.43, 2.45]

2 OHSS per couple Show forest plot

1

36

Odds Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

3 Pregnancy rate per couple (all cycles) Show forest plot

1

36

Odds Ratio (M‐H, Fixed, 95% CI)

1.27 [0.33, 4.97]

Figuras y tablas -
Comparison 9. In vitro fertilisation (IVF) versus intra‐uterine insemination (IUI) in cycles with ovarian hyperstimulation (OH)